CoChat

Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis

Open access
Balgobind, Brian V., Van Vlierberghe, Pieter, van den Ouweland, Ans M. W., Beverloo, H. Berna, Terlouw-Kromosoeto, Joan N. R., van Wering, Elisabeth R., Reinhardt, Dirk, Horstmann, Martin, Kaspers, Gertjan J. L., Pieters, Rob, Zwaan, C. Michel, Van den Heuvel-Eibrink, Marry M., Meijerink, Jules P. P. · 2008 · Blood
Cited by 139

The DOI matches its Crossref record.

Abstract

Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic disorder caused by mutations in the NF1 gene. Patients with NF1 have a higher risk to develop juvenile myelomonocytic leukemia (JMML) with a possible progression toward acute myeloid leukemia (AML). In an oligo array comparative genomic hybridization–based screening of 103 patients with pediatric T-cell acute lymphoblastic leukemia (T-ALL) and 71 patients with MLL-rearranged AML, a recurrent cryptic deletion, del(17)(q11.2), was identified in 3 patients with T-ALL and 2 patients with MLL-rearranged AML. This deletion has previously been described as a microdeletion of the NF1 region in patients with NF1. However, our patients lacked clinical NF1 symptoms. Mutation analysis in 4 of these del(17)(q11.2)-positive patients revealed that mutations in the remaining NF1 allele were present in 3 patients, confirming its role as a tumor-suppressor gene in cancer. In addition, NF1 inactivation was confirmed at the RNA expression level in 3 patients tested. Since the NF1 protein is a negative regulator of the RAS pathway (RAS-GTPase activating protein), homozygous NF1 inactivation represent a novel type I mutation in pediatric MLL-rearranged AML and T-ALL with a predicted frequency that is less than 10%. NF1 inactivation may provide an additional proliferative signal toward the development of leukemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2007-06-095075

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 139

Metadata

Authors
Balgobind, B. V., Van Vlierberghe, P., van den Ouweland, A. M. W., Beverloo, H. B., Terlouw-Kromosoeto, J. N. R., van Wering, E. R., Reinhardt, D., Horstmann, M., Kaspers, G. J. L., Pieters, R., Zwaan, C. M., Van den Heuvel-Eibrink, M. M., & Meijerink, J. P. P.
Venue
Blood
Published
2008-04-15
Volume
111
Issue
8
Pages
4322-4328
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2126788747
Cited by
139
References
0
FWCI
10.02
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis. https://app.cochat.ai/papers/10.1182/blood-2007-06-095075
The paper
Balgobind, B. V., Van Vlierberghe, P., van den Ouweland, A. M. W., Beverloo, H. B., Terlouw-Kromosoeto, J. N. R., van Wering, E. R., Reinhardt, D., Horstmann, M., Kaspers, G. J. L., Pieters, R., Zwaan, C. M., Van den Heuvel-Eibrink, M. M., & Meijerink, J. P. P. (2008). Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis. Blood. https://doi.org/10.1182/blood-2007-06-095075

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.